Table 6.

Notable MED12 Pathogenic Variants

Reference
Sequences
DNA Nucleotide
Change
Predicted Protein ChangeComment [Reference]
NM_005120​.3
NP_005111​.2
c.322C>Tp.Arg108TerDe novo variant w/15% mosaicism in a female w/HS [Li et al 2021]
c.514G>Cp.Glu172GlnDe novo variant in a female w/XLOS [Murakami et al 2020] & a female w/NSID [Polla et al 2021]
c.617G>Ap.Arg206GlnReported in males w/NSID [Donnio et al 2017, Srivastava et al 2019]
c.887G>Ap.Arg296GlnReported in persons w/XLOS [Patil et al 2017] & NSID [Amodeo et al 2020]
NM_005120​.3 c.1249-1G>C--De novo variant in 3 females w/NSID; leads to exon 9 skipping [Wang et al 2020, Polla et al 2021]
NM_005120​.3
NP_005111​.2
c.1547G>Ap.Arg516HisDe novo variant in a female w/NSID [Riccardi et al 2021]
c.1862G>Ap.Arg621GlnReported in male sibs w/NSID [Prescott et al 2016]
c.2207_2210delp.Thr736IlefsTer43De novo variant in a female w/HS [Li et al 2021]
c.2312T>Cp.Ile771ThrReported in male sibs & their niece w/NSID [Prontera et al 2016]
c.2444G>Ap.Arg815GlnReported in male sibs w/NSID [Charzewska et al 2018]
c.2661_2662insGp.Leu889ProfsTer11De novo variant in a female w/HS [Li et al 2021]
c.2669T>Ap.Ile890AsnDe novo variant in a female w/NSID [Riccardi et al 2021]
c.2692A>Gp.Asn898AspReported in a male w/FGS1 [Srivastava et al 2019] & a male w/NSID [Donnio et al 2017]
c.2735C>Tp.Ser912LeuDe novo variant in a female w/NSID [Polla et al 2021]
c.2786T>Ap.Val929AspDe novo variant in a female w/NSID [Polla et al 2021]
c.2861T>Gp.Val954GlyReported in male sibs w/NSID [Charzewska et al 2018]
c.2873G>Ap.Gly958GluReported in a family w/FGS1 [Rump et al 2011]
c.2881C>Tp.Arg961TrpMost common pathogenic variant in persons w/FGS1 [Risheg et al 2007, Clark et al 2009]
c.3020A>Gp.Asn1007SerRecurrent variant in persons w/LS [Schwartz et al 2007, Khan et al 2016]
c.3067A>Gp.Ile1023ValReported in a male w/NSID [Yamamoto & Shimojima 2015]
c.3271G>Ap.Glu1091LysReported in male cousins w/NSID [Charzewska et al 2018]
c.3412C>Tp.Arg1138TrpDe novo variant in 4 females w/NSID [Polla et al 2021, Riccardi et al 2021, Gonzalez et al 2021]
c.3443G>Ap.Arg1148HisReported in males w/XLOS [Vulto-van Silfhout et al 2013, Isidor et al 2014] & females w/NSID [Charzewska et al 2018]
c.3493T>Cp.Ser1165ProReported in a male w/XLOS [Vulto-van Silfhout et al 2013]
c.3640C>Tp.Arg1214CysReported in male sibs w/features of FGS1 & LS [Srivastava et al 2019]
c.3646G>Ap.Val1216MetDe novo variant in a female w/NSID [Polla et al 2021]
c.3653G>Ap.Gly1218GluDe novo variant in a female w/NSID [Polla et al 2021]
c.3883C>Tp.Arg1295CysReported in a family w/NSID [Rubinato et al 2020]
c.3884G>Ap.Arg1295HisReported in persons w/NSID [Charzewska et al 2018] & features of LS [Donnio et al 2017] & in male sibs w/features of FGS1 & LS [Srivastava et al 2019]
c.3932T>Ap.Val1311GluDe novo variant in a female w/NSID [Polla et al 2021]
c.3935T>Cp.Leu1312SerDe novo variant in a female w/NSID [Riccardi et al 2021]
c.4070G>Ap.Arg1357HisDe novo variant in a female w/NSID [Polla et al 2021]
c.4111C>Tp.Pro1371SerReported in a male w/NSID [Charzewska et al 2018]
c.4147G>Ap.Ala1383ThrReported in male sibs w/NSID [Langley et al 2015]
c.4400G>Ap.Arg1467GlnDe novo variant in a female w/NSID [Polla et al 2021]
c.4669T>Cp.Trp1557ArgDe novo variant in a female w/LS [Gonzalez et al 2021]
c.4832G>Ap.Arg1611HisReported in a male w/NSID [Narayanan & Phadke 2017]
c.4903_4906delinsCCAGCAp.Val1635ProfsTer61Presumed de novo variant in a female w/HS [Li et al 2021]
c.5111G>Ap.Trp1704TerDe novo variant in a female w/HS [Li et al 2021]
c.5185C>Ap.His1729AsnReported in a male w/XLOS [Vulto-van Silfhout et al 2013]
c.5622C>Ap.Tyr1874TerDe novo variant in a female w/HS [Li et al 2021]
c.5898dupCp.Ser1967GlnfsTer84Reported in males & females w/NSID [Lesca et al 2013]
c.5919C>Ap.Tyr1973TerDe novo variant in a female w/NSID [Polla et al 2021]
c.5922G>Tp.Gln1974HisReported in male sibs w/NSID [Bouazzi et al 2015]
c.6169C>Tp.Gln2057TerDe novo variant in a female w/HS [Li et al 2021]
c.6231C>Ap.Tyr2077TerDe novo variant in a female w/NSID [Polla et al 2021]
c.6250_6258delCAGCAGCAGp.Gln2084_Gln2086delReported in male sibs w/NSID & their unaffected mother [Lahbib et al 2019]
c.6268C>Tp.Gln2090TerDe novo variant in a female w/NSID [Polla et al 2021]
c.6280C>Tp.Gln2094TerDe novo variant in a female w/NSID [Polla et al 2021]
c.6448C>Tp.Gln2150TerDe novo variant in a female w/NSID [Polla et al 2021]
c.6476A>Cp.Gln2159ProReported in 3 male sibs w/XLOS [Rubin et al 2020]

FGS1 = FG syndrome type 1; HS = Hardikar syndrome; LS = Lujan syndrome; NSID = nonspecific intellectual disability; XLOS = X-linked Ohdo syndrome

Variants listed in the table have been provided by the author. GeneReviews staff have not independently verified the classification of variants.

GeneReviews follows the standard naming conventions of the Human Genome Variation Society (varnomen​.hgvs.org). See Quick Reference for an explanation of nomenclature.

From: MED12-Related Disorders

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.